Phase I clinical trial of a novel autologous modified-DC vaccine in patients with resected NSCLC
Pre-publication versions of this article are available by contacting email@example.com.
|15 Jul 2016||Submitted||Original manuscript|
|8 Feb 2017||Reviewed||Reviewer Report - Abhishek Garg|
|14 Feb 2017||Reviewed||Reviewer Report - Shigetaka Shimodaira|
|18 Feb 2017||Reviewed||Reviewer Report - Tuncay Göksel|
|24 Jul 2017||Author responded||Author comments - Chunlei Ge|
|Resubmission - Version 2|
|24 Jul 2017||Submitted||Manuscript version 2|
|28 Jul 2017||Reviewed||Reviewer Report - Abhishek Garg|
|29 Nov 2017||Author responded||Author comments - Chunlei Ge|
|Resubmission - Version 3|
|29 Nov 2017||Submitted||Manuscript version 3|
|29 Nov 2017||Editorially accepted|
|21 Dec 2017||Article published||10.1186/s12885-017-3859-3|
How does Open Peer Review work?
Open peer review is a system where authors know who the reviewers are, and the reviewers know who the authors are. If the manuscript is accepted, the named reviewer reports are published alongside the article. Pre-publication versions of the article are available by contacting firstname.lastname@example.org.
You can find further information about the peer review system here.